Suppr超能文献

用于高效靶向药物递送的外泌体工程:现状与未来展望

Exosome engineering for efficient and targeted drug delivery: Current status and future perspective.

作者信息

Malekian Farzaneh, Shamsian Alireza, Kodam Sai Priyanka, Ullah Mujib

机构信息

Institute for Immunity and Transplantation, Stem Cell Biology and Regenerative Medicine, School of Medicine, Stanford University, Palo Alto, CA, USA.

Molecular Medicine Department of Medicine, Stanford University, Palo Alto, CA, USA.

出版信息

J Physiol. 2023 Nov;601(22):4853-4872. doi: 10.1113/JP282799. Epub 2022 Jun 2.

Abstract

Exosomes are membrane-bound vesicles that are released by most cells. They carry nucleic acids, cytokines, growth factors, proteins, lipids, and metabolites. They are responsible for inter- and intracellular communications and their role in drug delivery is well defined. Exosomes have great potential for therapeutic applications, but the clinical use is restricted because of limitations in standardized procedures for isolation, purification, and drug delivery. Bioengineering of exosomes could be one approach to achieve standardization and reproducible isolation for clinical use. Exosomes are important transporters for targeted drug delivery because of their small size, stable structure, non-immunogenicity, and non-toxic nature, as well as their ability to carry a wide variety of compounds. These features of exosomes can be enhanced further by bioengineering. In this review, possible exosome bioengineering approaches, their biomedical applications, and targeted drug delivery are discussed.

摘要

外泌体是大多数细胞释放的膜结合囊泡。它们携带核酸、细胞因子、生长因子、蛋白质、脂质和代谢产物。它们负责细胞间和细胞内通讯,其在药物递送中的作用已得到明确界定。外泌体在治疗应用方面具有巨大潜力,但由于分离、纯化和药物递送的标准化程序存在局限性,其临床应用受到限制。外泌体的生物工程可能是实现临床应用标准化和可重复分离的一种方法。由于外泌体体积小、结构稳定、无免疫原性、无毒,以及能够携带多种化合物,因此它们是靶向药物递送的重要载体。外泌体的这些特性可以通过生物工程进一步增强。在本综述中,讨论了外泌体生物工程的可能方法、其生物医学应用和靶向药物递送。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验